
Opinion|Videos|November 8, 2024
Unmet Needs in Generalized Myasthenia Gravis
Key Takeaways
- Current MG treatments often have limited efficacy and significant side effects, necessitating more effective and targeted therapies.
- Early and accurate diagnosis is crucial, highlighting the need for better diagnostic tools in MG management.
Panelists discuss how certain aspects of myasthenia gravis management remain challenging, identifying ongoing unmet needs in diagnosis, treatment, and patient care.
Advertisement
Video content above is prompted by the following:
- What continue to be unmet needs in myasthenia gravis?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
2
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
3
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
4
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
5

















